详情页 - 河北医科大学第四医院机构库

资源类型：

文章类型：

作者：

Song, Yuqin[1] * ; Tang, Xiaoqiong[2] ; Cai, Qingqing[3] ; Liu, Lihong[4] ; Jing, Hongmei[5] ; Jiang, Ming[6] ; Sun, Xiuhua[7] ; Wu, Jianqiu[8] ; Yang, Yu[9] ; Wu, Huijing[10] ; Peng, Zhigang[11] ; Ding, Kaiyang[12] ; Yi, Shuhua[13] ; Yan, Xiaojing[14] ; Wu, Guowu[15] ; Wu, Yudan[16] ; Cui, Jie[17] ; Ou, Pengju[18] ; Tan, Fenlai[19] ; Zhu, Jun[20] ;

机构： [1]Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China [2]Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, China [3]Urinary Surgery Center, Hunan Cancer Hospital, Changsha, China [4]Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China [5]Department of Urology Surgery, Chongqing Cancer hospital, Chongqing, China [6]Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China [7]Anhui Provincial Cancer Hospital, Hefei, China [8]Department of Cancer Centre, First Hospital of Jilin University, Changchun, China [9]Urinary Surgery Center, Nanjing Drum Tower Hospital, Nanjing, China [10]Tianjin Cancer Hospital, Tianjin, China [11]Qilu Hospital of Shandong University, Jinan, China [12]West China Hospital, Sichuan University, Chengdu, China [13]Peking Union Medical College Hospital, Beijing, China [14]Zhongshan Hospital, Fudan University, Shanghai, China [15]Chinese PLA General Hospital, Beijing, China [16]Tongji Hospital, Wuhan, China [17]Weifang People′s Hospital, Weifang, China [18]Pathology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China [19]School of Life Science and Technology, Tongji University, Shanghai, China [20]Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China

出处：

ISSN：

语种：

WOS：

中科院分区：

出版当年[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2024]版：

无

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

An open label, single arm, multicenter phase II study of the efficacy and safety of LP-168 monotherapy for relapsed or refractory mantle cell lymphoma

文献详情